Roeland Nusse - Oct 24, 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
Andrew Nick as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed
Stock symbol
TECH
Transactions as of
Oct 24, 2024
Transactions value $
$0
Form type
4
Date filed
10/28/2024, 04:41 PM
Previous filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +1.46K +3.39% $0.00 44.6K Oct 24, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +3.51K $0.00 3.51K Oct 24, 2024 Common Stock 3.51K $68.37 Direct F1
holding TECH Stock Options (Right to Buy) 17K Oct 24, 2024 Common Stock 17K $21.84 Direct
holding TECH Stock Options (Right to Buy) 15.9K Oct 24, 2024 Common Stock 15.9K $25.30 Direct
holding TECH Stock Options (Right to Buy) 12.5K Oct 24, 2024 Common Stock 12.5K $31.26 Direct
holding TECH Stock Options (Right to Buy) 7.59K Oct 24, 2024 Common Stock 7.59K $44.96 Direct
holding TECH Stock Options (Right to Buy) 8.04K Oct 24, 2024 Common Stock 8.04K $50.41 Direct
holding TECH Stock Options (Right to Buy) 6.03K Oct 24, 2024 Common Stock 6.03K $63.92 Direct
holding TECH Stock Options (Right to Buy) 2.53K Oct 24, 2024 Common Stock 2.53K $128.81 Direct
holding TECH Stock Options (Right to Buy) 3.46K Oct 24, 2024 Common Stock 3.46K $73.94 Direct
holding TECH Stock Options (Right to Buy) 3.94K Oct 24, 2024 Common Stock 3.94K $61.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.